{"id":48382,"date":"2021-12-18T06:02:45","date_gmt":"2021-12-18T06:02:45","guid":{"rendered":"https:\/\/dailysouthafrica.com\/?p=48382"},"modified":"2021-12-18T06:02:45","modified_gmt":"2021-12-18T06:02:45","slug":"concentric-by-ginkgo-and-xprescheck-confirm-first-north-american-detections-of-novel-ba-3-sublineage-of-omicron-variant-through-cdc-covid-19-air-travel-biosecurity-program","status":"publish","type":"post","link":"https:\/\/dailysouthafrica.com\/concentric-by-ginkgo-and-xprescheck-confirm-first-north-american-detections-of-novel-ba-3-sublineage-of-omicron-variant-through-cdc-covid-19-air-travel-biosecurity-program\/","title":{"rendered":"Concentric By Ginkgo And XpresCheck\u2122 Confirm First North American Detections Of Novel BA.3 Sublineage Of Omicron Variant Through CDC COVID-19 Air Travel Biosecurity Program"},"content":{"rendered":"
<\/div>\n
Published by
The Street<\/div>\n
<\/div>\n

By PR Newswire BOSTON, Dec. 18, 2021 \/PRNewswire\/ — Ginkgo Bioworks (DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant. Samples came from passengers on flights originating from South Africa who arrived at Newark Liberty International Airport (EWR) in early December. These samples were collected in collaboration with the Centers for Disease Control and Prevention (CDC) and XpresSpa Group, Inc. (Nasdaq: XSPA) as part of a SARS-CoV-2 surveillance project that involves voluntary sampling of arriving inte…<\/p>\n

Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Published by The Street By PR Newswire BOSTON, Dec. 18, 2021 \/PRNewswire\/ — Ginkgo Bioworks (DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant. Samples came from passengers on flights originating from South Africa who arrived at Newark Liberty International Airport (EWR) in … <\/p>\n